Midday pulse, April 27, 2026: S&P 500 edges lower near 7,163 as Iran Hormuz bid and MSFT-OpenAI split weigh

NEW YORK, April 27, 2026 — U.S. equities were fractionally lower at midday Monday, with the S&P 500 trading near 7,163 (approximately -0.03% from Friday’s close), the Nasdaq Composite near 24,812 (approximately -0.16%), the Dow Jones Industrial Average near 49,143 (approximately -0.05%), and the Russell 2000 essentially flat at around 0.00% — a subdued session shaped by two dominant macro and corporate narratives that pulled sentiment in opposing directions.

The session’s near-stillness at the index level masked genuine turbulence beneath the surface, with wide dispersion among individual names and elevated cross-asset volatility as traders assessed fresh signals from the Middle East and a structural shift in the artificial intelligence sector’s most closely watched partnership.

What is driving the tape

Two catalysts dominated Monday’s session from the opening bell. First, Iran submitted a formal proposal to Washington for reopening the Strait of Hormuz, the waterway through which approximately 20% of global seaborne oil flows, while suggesting that nuclear negotiations be deferred to a separate track. The proposal was received with cautious optimism but fell short of triggering a decisive risk-on rotation, as analysts noted that the gap between a proposal and a verified ceasefire remained substantial.

The geopolitical development arrived against a backdrop of dramatically repriced energy markets. Brent crude’s fourth-quarter 2026 price outlook was raised to $90 per barrel, up from a prior forecast of $80 and representing a figure nearly $30 higher than pre-Hormuz-shock projections. That revision carries significant downstream implications for energy sector earnings, inflation expectations, and Federal Reserve optionality — three variables that equity markets have been repricing since the Strait closure was first announced.

As covered in PreMarket Daily’s premarket roundup this morning, S&P 500 futures had already flagged a cautious open, slipping to 7,188 as the Iran headline crossed wires before dawn. The index’s subsequent inability to hold those levels through midday reflected an underlying ambivalence: a Hormuz reopening, if confirmed, would be unambiguously positive for growth and inflation, but traders have learned in recent weeks to demand verification before pricing in Middle East diplomatic progress.

The second dominant driver was corporate and structural. OpenAI announced a significant restructuring of its years-long exclusive partnership with Microsoft, replacing the existing revenue-sharing arrangement with a fixed payment model through 2030. Microsoft opened the session underwater as markets digested the implications: the new structure removes Microsoft’s direct participation in OpenAI’s revenue upside, a key element of the bull case that helped power the stock to record levels in 2025 and early 2026.

Data Visual

Midday index performance April 27

Shows how each major U.S. index is performing at midday versus the prior close, giving traders an at-a-glance read on broad market direction.

Values in %

Standout midday movers

Top gainer: Veradermics (MANE) +45%

Biopharma company Veradermics (MANE) surged approximately 45% at midday after the company released positive topline results from its Phase 2/3 clinical trial. The result cleared the session’s highest bar for a positive surprise, generating a volume spike characteristic of institutional repositioning rather than purely retail momentum. Biopharma Phase 2/3 readouts of this magnitude typically prompt immediate analyst coverage initiation and target-price cascades in subsequent sessions.

Standout decliner: Poet Technologies (POET) -50%

Poet Technologies (POET) fell nearly 50% to approximately $8 after the chip-scale photonic solutions company disclosed that it had cancelled all purchase orders previously placed by Celestial AI. The announcement removed a cornerstone revenue relationship from Poet’s near-term commercial pipeline and raised immediate questions about order book concentration risk. The move is among the most severe single-session drawdowns in the semiconductor supply chain space this year.

Notable earnings movers

Domino’s Pizza (DPZ) fell 10.5% after missing Wall Street’s first-quarter earnings expectations, adding to pressure on the consumer discretionary sector. Conversely, Verizon (VZ) gained 3.5% after the communications giant raised its fiscal 2026 adjusted earnings outlook, providing a rare positive earnings catalyst in the large-cap space on a session otherwise defined by disappointments and structural uncertainty.

Data Visual

Top midday movers April 27

Highlights the session’s most significant individual stock moves at midday, illustrating the dispersion between earnings winners and losers.

Values in %

Sector rotation check

The sector picture at midday reflected the cross-current nature of Monday’s dominant themes. Energy was among the better-performing sectors, supported by the $90 Brent Q4 forecast revision even as the Iran proposal introduced a potential ceiling on further crude appreciation. The energy trade remained fundamentally long-volatility rather than directionally bullish: a verified Hormuz reopening would reverse the oil premium sharply, while a breakdown in talks would extend it.

Technology lagged the broader tape, weighed by Microsoft’s partnership restructure and the broader de-risking of AI-premium valuations. The Nasdaq’s underperformance relative to the Dow and S&P 500 at midday — approximately -0.16% versus -0.05% and -0.03% respectively — reflected that sector-specific drag rather than a broad growth rotation.

Communications services received a modest bid from Verizon’s raised guidance, though the move was insufficient to lift the sector materially. Consumer discretionary faced pressure from Domino’s 10.5% decline. Healthcare attracted attention from Veradermics’ Phase 2/3 result, though single-name biopharma moves of this magnitude rarely translate into sustained sector-level momentum absent a broader catalyst.

This follows the pattern established last Thursday when, as detailed in this morning’s opening bell coverage of Organon’s 25% surge on Sun Pharma’s $11.75 billion acquisition, the healthcare sector has seen a disproportionate share of M&A and clinical catalysts relative to its index weight this earnings season.

What to watch into the close

Several variables will determine whether the afternoon session produces a directional break or continues Monday’s sideways drift.

The macro calendar is light for the remainder of Monday’s session, shifting attention squarely to the after-hours earnings slate and any further diplomatic developments from the Iran-U.S. Hormuz channel. The week’s most significant scheduled data events — including FOMC commentary and core PCE — remain ahead, as outlined in PreMarket Daily’s week-ahead briefing published Sunday.

For context on the S&P 500’s recent record-setting trajectory, the April 24 close at a record 7,165, driven by Intel’s 23% surge on blowout earnings, established the benchmark against which Monday’s midday session is being measured — and which has thus far proved difficult to meaningfully extend.

Monday’s afternoon setup is characterised by low-conviction drift rather than directional momentum. Index-level moves have been marginal, but the dispersion in individual names — with a 50% collapse in POET, a 45% surge in MANE, and a 10.5% drop in DPZ within the same session — indicates that the market is not in a low-volatility regime at the stock level. Traders approaching the close should note that the dominant macro variable, the Iran Hormuz proposal, remains unresolved: a positive development before 4 PM ET would likely generate a sharp late-day rally, while silence or a negative update would allow the current cautious tone to persist into Tuesday’s pre-market.